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The 1918 ‘‘Spanish flu’’ was the fastest spreading and most deadly
influenza pandemic in recorded history. Hypotheses of its origin
have been based on a limited collection of case and outbreak
reports from before its recognized European emergence in the
summer of 1918. These anecdotal accounts, however, remain
insufficient for determining the early diffusion and impact of the
pandemic virus. Using routinely collected monthly age-stratified
mortality data, we show that an unmistakable shift in the age
distribution of epidemic deaths occurred during the 19171918
influenza season in New York City. The timing, magnitude, and age
distribution of this mortality shift provide strong evidence that an
early wave of the pandemic virus was present in New York City
during February–April 1918.
age-specific mortality  epidemic  herald wave  Spanish flu
The origin of the 1918 inf luenza pandemic remains elusive.The causes for its transmissibility, virulence, and unique
age pattern remain inadequately understood. In less than 2
years, the pandemic killed 675,000 people in the United
States (1) and 40–100 million worldwide (2, 3), with the
majority of deaths occurring among those 45 years old (4).
Analysis of viral RNA recovered from preserved lung-tissue
samples from geographically distant regions confirms that the
pandemic wave in the northern hemisphere in the autumn of
1918 and its recrudescence in winter 1919 were caused by an
AH1N1 inf luenza virus with a highly conserved hemagglu-
tinin gene identified in two antigenic configurations (5–7).
Whether the epidemic recognized as ‘‘Spanish f lu’’ in Europe
in the summer of 1918 (4) was caused by a similarly conserved
virus is unknown, and whether anecdotal cases and outbreaks
reported from Europe in 1916 and 1917 (8) and the United
States in early 1918 (9–11) were caused by a virus related to
the pandemic virus remains speculative.
At the peak of the catastrophic wave in the autumn of 1918,
an influenza-like epidemic the preceding spring was retrospec-
tively described as an early wave of the pandemic (9). At the end
of the 19181919 season, an epidemiological study suggested that
this early precursor wave had caused epidemic mortality in
Atlantic seaboard cities before central and western U.S. cities
(10). A limited collection of eyewitness case and outbreak
reports, however, led to the consensus view that the pandemic
emerged in a mild wave in the spring of 1918 from an isolated
rural region in the central United States (11). This view became
widely accepted (12–15), without rigorous reevaluation of the
original evidence.
Reanalysis of contemporary studies and routinely collected
data may provide insight into the epidemiology of the 1918
pandemic (16–18). A characteristic feature of inf luenza epi-
demiology has historically been that the burden of excess
mortality in interpandemic seasons occurs primarily in older
age groups, whereas the burden in pandemic seasons shifts
disproportionately to younger ages (19). During and following
each of the three major 20th-century pandemics in which this
pattern occurred, in subsequent epidemic seasons, the burden
of mortality shifted proportionally back to older age groups
(19, 20). In this study, we compare age-specific mortality
patterns from inf luenza epidemics in New York City from 1911
to 1921. Although absolute confirmation of a precursor wave
depends on recovery of viral RNA, we present here an
epidemiological analysis showing that the pattern of age-
specific epidemic excess mortality shifted strongly toward
younger age groups in the winter preceding the pandemic wave
in the autumn of 1918. This result provides evidence that
a prepandemic herald wave of mortality occurred during
February–April 1918 in New York City.
Materials and Methods
We obtained historical monthly mortality statistics from New
York City Health Department records. All-cause and pneumo-
nia and influenza (P&I) deaths from 1907 to 1921 were used in
our all-ages analyses. All-cause deaths during 1911–1921, strat-
ified into six age groups (5, 5–14, 15–24, 25–44, 45–64, and
65), were used in our age-specific analyses. We standardized
observed deaths by length of month and calculated rates by using
New York City population estimates linearly interpolated from
1910 and 1920 U.S. census reports.
The model approach we used was originally developed for
measuring the impact of influenza epidemics by estimating an
expected baseline level to which observed epidemic period
deaths were compared (21–23). Other studies have similarly
estimated baseline mortality from weekly or monthly deaths,
exclusive of epidemic periods, by using least-squares regression
with sinusoidal terms. Although alternatives have been devel-
oped (24–26) and variations on this model have continued to be
widely used (27–30), excess mortality remains an insensitive
measure of severity, particularly in pediatric populations (1). We
used the same monthly baseline equation with annual and
6-month-cycle terms for total P&I and for total and age-specific
all-cause mortality analyses:
Mt  0  1t  1cos2 t12  1sin2 t12
 2cos4 t12  2sin4 t12  et.
Our estimate of expected deaths at time t (Mt) was determined
by the constant 0, secular trend 1, annual predictors 1 and
1, semiannual predictors 2 and 2, and an error term et,
derived from linear regression of nonepidemic monthly mor-
tality data. We purged months that the New York City Health
Department reported increased respiratory disease activity or
a major mortality event such as summer diarrheal epidemics,
the 19151916 inf luenza epidemic, the 1916 polio epidemic, or
the 1917 heat wave. For each available 5-year period of
mortality data, we projected out the expectation and an
arbitrarily defined 95% confidence limit and purged months
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exceeding this threshold. Each 5-year series and annual fore-
cast was for August through July.
To focus on the most severe seasons, we arbitrarily defined
an inf luenza season epidemic as two or more consecutive
months when observed P&I mortality exceeded the upper 95%
confidence limit of the baseline. Excess deaths were calculated
for each epidemic season as the difference between expected
and observed mortality for the consecutive epidemic months.
Fig. 1. All-cause and P&I monthly mortality rates for all ages (A and B) and all-cause mortality rates by age group (C–H) are calculated per 10,000 population.
Observed rates are days-per-month adjusted. Expected model baselines (solid lines) are derived from each series of nonepidemic months. Epidemic thresholds
(dashed lines) are the upper 95% confidence limit above each baseline. The major epidemic influenza season months are indicated (shaded). Two 19171918
influenza season peaks (arrowheads) show excess mortality primarily confined to the 65-years age group in January (C), and to the groups 45 years old in
March 1918 (E–H). Other severe mortality events are evident: summer diarrheal disease epidemics were confined to young children (H), the 1916 polio epidemic
to all children (G and H), and the summer 1917 heat wave and diarrheal disease epidemic among the youngest and oldest age groups (C and H).
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Total and age-specific estimates of excess deaths were deter-
mined for the same months. Seasonal excess deaths from
all-cause and P&I data for the entire population were com-
pared, along with all-cause 45 and 45 excess death esti-
mates. Due to the characteristic 1918 pattern of mortality and
the age groupings available, we calculated the risk ratio (20) of
45 to 45 excess death rates to provide a single measure of
relative risk of inf luenza-related death by age during the
inf luenza periods identified by the model.
We obtained annual P&I mortality rates by age group for
1915–1917 to look for the typical ‘‘U-shaped’’ mortality curve
(increased rates at the extremes of age) and for 1918 to look
for the ‘‘W-shaped’’ curve characteristic of the pandemic
(highest annual mortality rates among young children, young
adults, and the elderly). To provide an alternative measure of
the age-specific impact on interpandemic and pandemic in-
f luenza-related deaths, excess mortality rates were plotted by
age and compared for the severe 19151916 inf luenza season,
the March and April 1918 epidemic months, and the 19181919
pandemic season. As done recently to characterize mortality
age patterns for the 1968 pandemic (31), we calculated the
age-specific ratio of pandemic to interpandemic excess rates to
estimate age-specific relative risk by using 45 years of age as
the cutoff.
Results
Excess Mortality. Severe epidemic mortality occurred in 5 of the
10 inf luenza seasons during 1911–1921. The 19111912 inf lu-
enza season was reported by the health department as dis-
tinctly free of epidemic inf luenza, and the 19151916 inf lu-
enza epidemic was noted at the time as the worst to date that
century (4). During the 1915–1920 epidemic seasons, the
temporal pattern and peaks in all-cause and P&I deaths
coincided (Fig. 1 A and B). Epidemic period estimates for all
ages in the 19151916 and 19161917 seasons were 2,100 and
2,800 excess all-cause deaths, respectively (Table 1). Excess
all-cause deaths in the 19181919 pandemic and 19191920
recrudescence were 29,200 and 8,200, respectively (Table 1).
An estimated 4,600 excess all-cause deaths occurred during the
19171918 inf luenza season (Table 1); epidemic mortality in
this season occurred in two peaks, in January and March 1918
(Fig. 1 A and B, arrowheads).
Age-Specific Analyses. The age pattern of mortality shifted
profoundly during the 19171918 season. In the 19151916 and
19161917 inf luenza seasons and in January 1918, excess
mortality incidence was greatest in those 65 years old (Fig.
1 C). During February–April 1918 and the 19181919 season,
those 65 years old experienced little or no excess mortality
(Fig. 1C), whereas those aged 15–24 and 25–44 years experi-
enced sharply elevated death rates (Fig. 1 E and F). Mortality
data for children 5 and 5–14 years old did not exhibit winter
peaks before the 19171918 season (Fig. 1 G and H). Before
1918, children experienced mortality peaks from summer
diarrheal disease epidemics, a severe polio epidemic in the
summer of 1916 (Fig. 1 G and H), and a coincident diarrheal
epidemic and heat wave in the summer of 1917 (Fig. 1H).
Because of the striking contrast in mortality impact by
age during the 19181919 pandemic season, we calculated the
ratio of 45 to 45 years epidemic period excess death
rates (Table 1). The ratio of age-specific epidemic deaths
shifted abruptly in February 1918 and reached values 20-fold
higher in March and April 1918 and in the 19181919 sea-
son than in the 19151916 and 19161917 epidemic seasons
(Table 1). The age-specific ratio in the 19191920 season was
closer to prepandemic levels (Table 1); however, the total
burden of excess deaths among people 45 years old remained
extremely high, compared with the interpandemic period
(Fig. 1 E–H).
The W-Shaped Curve. Average annual P&I death rates by age for
1915–1917 showed the classic U-shaped mortality pattern
characteristic of inf luenza epidemic years (Fig. 2A). For
calendar year 1918, the age-specific mortality pattern showed
the classic W-shaped distribution of the pandemic (Fig. 2 A).
In contrast, when we plotted seasonal age-specific excess
mortality rates (specifically representing inf luenza-related
Fig. 2. Annual and epidemic period mortality rates by age group. (A)
Average age-specific calendar year P&I death rates are plotted in a U-shaped
age distribution for 1915–1917 (E), and in the characteristic W-shaped distri-
bution for the pandemic year 1918 (■ ). (B) Influenza-season-attributable
excess deaths are plotted for the 19151916 epidemic influenza season (E),
the epidemic months March and April 1918 (Œ), and the pandemic season from
September 1918 through April 1919 (■ ). (C) The excess rates are plotted on a
log10 scale. (D) Relative risk of death is plotted by age group on a log10 scale
for the March and April 1918 epidemic period (Œ) and the pandemic from
September 1918 through April 1919 (■ ) relative to the severe 19151916
epidemic season.











mortality), a strikingly different pattern emerged. For the
19151916 interpandemic season, the U pattern is f lattened on
one end because children 5 years had little excess epidemic-
period impact, whereas the U pattern was elevated on the
other, because the greatest increase in epidemic period mor-
tality was among the elderly (Fig. 2B). For the 19181919
pandemic season, mortality rates in young children and young
adults were sharply higher than for the 19151916 epidemic,
whereas mortality rates were lowest among the oldest age
group, presenting an age pattern resembling an attenuated W
shape (Fig. 2B).
The age pattern of excess epidemic death rates in early 1918,
when the risk ratio shifted toward younger ages (Table 1), is not
immediately apparent as plotted (Fig. 2B). However, on a
logarithmic scale, the relative pattern appears strikingly similar
to the 19181919 pandemic period, and the 19151916 epidemic
pattern clearly was different from both the early 1918 epidemic
and the 19181919 season (Fig. 2C). To further illustrate the age
pattern as a measure of mortality risk, the ratio of the early 1918
epidemic and 19181919 pandemic periods relative to the 1915
1916 epidemic are plotted (relative risk, Fig. 2D); this graph
underscores that the oldest age groups fared better during these
periods than during a typical severe influenza epidemic season
such as 19151916.
Discussion
In the absence of virological evidence of an early wave of the
1918 pandemic, we have alternatively pursued an epidemio-
logical approach based on previously unexploited age-detailed
mortality data from New York City, which at the time com-
prised 5% of the entire U.S. population. In this study, we
have characterized the age-specific impact of inf luenza epi-
demics on mortality for 1911–1921 to identify and determine
the timing of a ‘‘signature’’ age shift previously shown to
distinguish pandemic from epidemic inf luenza periods (19).
We have demonstrated that a distinct shift in the age distri-
bution of excess deaths occurred during the 19171918 season
in a pattern suggestive of a herald wave of pandemic mortality.
A prevailing hypothesis of the 1918 pandemic’s origin has been
that it emerged in a mild wave in the spring of 1918 from the
central United States (11–15); however, the original data
supporting this argument have never been rigorously evalu-
ated. The data we present for New York City suggest that
prepandemic activity was occurring before spring 1918, and
that the impact was far from mild. These findings are incon-
sistent with the prevailing hypothesis of a spring 1918 Kansas
origin, and they reopen the possibility that the virus had spread
from Europe to New York City in the context of troop
movement during World War I.
The severe wave of mortality from February to April 1918 in
New York City caused more than one-tenth the number of excess
all-cause deaths as occurred during the subsequent pandemic
season. The impact of the early wave on young adults was
extreme, with a peak associated with a doubling of all-cause
deaths among 15- to 24-year-olds (Fig. 1F), and the impact on
the oldest age group was typical of nonepidemic period winter
mortality (Fig. 1C). If the 19181919 pandemic season had never
occurred, the age-specific impact of the early 1918 epidemic
would remain an unprecedented event in the history of New
York City municipal mortality statistics. With the exception of
the 19181919 pandemic season, no reported influenza-like
respiratory disease epidemic, other than the proposed herald
wave that we report, has ever caused such an extreme increase
in young adult deaths while causing little or no impact among
older adults. The relative impact on the young and the lack of
impact on the oldest age group present similar patterns for both
the herald and pandemic waves, compared with surrounding
epidemic seasons (Fig. 2D).
Based on calendar-year data, the age pattern of the 1918
pandemic has typically been described as W-shaped, with high
mortality rates in three age groups: very young children, young
adults, and the elderly (Fig. 2A). Our study, which attempts to
provide an estimate of epidemic inf luenza-attributable deaths,
specifically shows that during pandemic months, the oldest age
group experienced little increase in mortality, thus attenuating
the older end of the W curve (Fig. 2B). Other studies have
similarly shown this lack of impact in older age groups, based
on quarterly (32) and annual (33) data. And other studies have
shown a similar pandemic shift in age-specific relative risk, in
the case of the 1968 AH3N2 pandemic (31), consistent with
serological evidence of previous exposure to a similar anti-
genic subtype virus among those 77 years old (34). The
relative sparing of the oldest age groups in our study is
consistent with the hypothesis of protection due to the recy-
cling of a similar virus subtype a half-century earlier (34) and
also with the hypothesis that antibody-dependent enhance-
ment led to extreme virulence, specifically in younger adults
(35). We could not address these possibilities further with the
data at hand, and we did not have the age detail to further
characterize the age cutoff among the middle age groups
that would separate those affected from those not affected by
this inf luenza pandemic. Furthermore, we did not have the
spatial and temporal detail necessary to further characterize
precisely when and where the pandemic mortality herald wave
began.
Table 1. Influenza season excess deaths
Epidemic period*
Number of excess deaths (rate per 10,000 population)†
Risk ratio‡
45:45AC P&I AC 45 AC 45
December 1915–February 1916 2,100 (4.0) 1,600 (3.0) 600 (1.3) 1,400 (14.9) 0.1
December 1916–February 1917 2,800 (5.3) 1,600 (3.0) 800 (1.8) 2,100 (21.2) 0.1
December 1917 and January 1918 1,500 (2.8) 600 (1.1) 1,000 (2.3) 400 (3.9) 0.6
February 1918 400 (0.7) 200 (0.5) 400 (0.8) 100 (0.6) 1.3
March and April 1918 2,700 (4.9) 1,900 (3.5) 2,500 (5.6) 200 (2.1) 2.6
September 1918–April 1919 29,200 (53.0) 28,600 (51.8) 26,200 (58.7) 2,100 (20.3) 2.9
January–March 1920 8,200 (14.6) 6,000 (10.7) 5,400 (11.8) 1,800 (16.5) 0.7
*Epidemic periods are consecutive months when P&I mortality exceeded the arbitrarily defined threshold. The 19171918 influenza
season is broken down by period to illustrate the changing age distribution.
†Excess total all-cause (AC) and P&I mortality estimates are derived from the total population data. Excess AC 45 and AC 45 mortality
estimates are derived from the 45 and the 45 age groups. The difference between total all-cause and the sum of age-specific all-cause
values was due to rounding and variation between the total and age-stratified analyses.
‡The risk ratio is derived from the AC 45 and AC 45 excess mortality rates.
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A shift in the relative distribution of mortality toward
younger ages occurred in each of the three major pandemics
of the 20th century (19, 20). Whether and to what degree early
evidence of the 1918 pandemic shift can be identified in other
cities remains an important test of our hypothesis. Although
our approach can detect only a significant mortality impact and
would miss any sporadic pandemic activity, the magnitude and
age specificity of the early 1918 epidemic that we describe
suggest that such an early wave may be identifiable in much
smaller regional data sets. However, the recovery of AH1N1
inf luenza virus RNA from human tissue from this period
remains the gold standard for identifying a precursor epidemic
wave.
Since the original confirmation that an AH1N1 inf luenza
virus caused the 1918 pandemic (5), further phylogenetic
characterization of the virus (6, 7, 36) and elucidation of its
hemagglutinin structure (37, 38) have presented a complex
and inconclusive evolutionary story of an avian-like mamma-
lian-adapted virus, more like the H5N1 avian inf luenza vi-
ruses that have been isolated since 1997 than the pandemic
reassortments of either 1957 or 1968 (39, 40). Our epidemio-
logical approach cannot provide insight into the specific
genetic characteristics of the virus that caused the observed
early 1918 epidemic. However, the most parsimonious
explanation is that the virus that caused the early wave was
similar to that which caused the catastrophic wave that ex-
ploded globally in the autumn of 1918. We believe that the
magnitude of the increase in young-adult deaths accompanied
by the lack of impact among older age groups provides
compelling evidence of an early phase or herald wave of the
1918 pandemic.
Further analysis of age-detailed historical mortality data
from other regions and periods may continue to provide
insight into the epidemiology of past inf luenza pandemics and
may help to inform current preparedness planning efforts for
future pandemics (41). The historical–epidemiological evi-
dence of the precursor wave that we present, along with a
recent study of transmissibility in the pandemic wave of
autumn 1918 (42), suggest that if events similar to those
preceding autumn 1918 were to occur again, strengthened
surveillance and increased capacity for rapid public health
intervention could possibly prove critical in limiting the emer-
gence and impact of the next pandemic. The speed with which
human-to-human transmissibility of a highly pathogenic mam-
malian adapted avian inf luenza virus develops cannot cur-
rently be predicted. Nevertheless, the historical precedent of
20th-century inf luenza pandemics suggests that theoretically
controllable transmissibility and a herald wave may occur
before the onset of a catastrophic pandemic wave, leaving a
critical window of opportunity for production and distribution
of pandemic vaccines and antivirals.
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